Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation

Melissa M. Rosas, Michal J. Sobieszczyk, Whittney Warren, Phillip Mason, Robert J. Walter, Joseph E. Marcus*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


There are limited data on the treatment of fungal infections complicating extracorporeal membrane oxygenation (ECMO). In 14 patients who developed fungal bloodstream infections on ECMO, 8 (57%) survived to discharge. Of the 5 patients completing treatment prior to decannulation, 2 (40%) developed recurrent fungal infections.

Original languageEnglish
Article numberofac374
JournalOpen Forum Infectious Diseases
Issue number8
StatePublished - 1 Aug 2022
Externally publishedYes


  • COVID-19
  • extracorporeal membrane oxygenation
  • fungemia


Dive into the research topics of 'Outcomes of Fungemia in Patients Receiving Extracorporeal Membrane Oxygenation'. Together they form a unique fingerprint.

Cite this